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Background: The role of conventional bone scintigraphy in diagnosing early axial spondyloarthritis (SpA) is yet
controversial. Single positron emission computed tomography (SPECT) plus CT is an imaging modality that adds
better anatomical information to scintigraphy of the sacroiliac (SI) joint. Our aim was to investigate the usefulness
of bone SPECT/CT with volume of interest (VOI) analysis in early axial SpA patients.
Methods: Twenty patients (male: female ratio = 12:8; age range = 17–65 years) presenting with inflammatory back
pain meeting the Amor criteria of early axial SpA were recruited from a single center in South Korea. Bone scintigraphy
was performed 180 min after intravenous injection of 1110 MBq of Tc-99 m-HDP, followed by bone SPECT/CT. The ratio
between the entire SI joint and sacrum (SIS ratio) was measured by both bone SPECT/CT and bone scintigraphy. Data
from 13 controls were also evaluated. Receiver operating characteristic (ROC) curve was plotted for further analysis, and
the correlation between the SIS ratio and SI joint grade by plain radiography was assessed.
Results: The SIS ratio of early axial SpA patients vs. control subjects was significantly increased in bone SPECT/CT
(p < 0.001). However, no significant difference was detected in bone scintigraphy. ROC curve analysis showed a
significant difference in the area under curve (AUC) of bone SPECT/CT vs. bone scintigraphy (0.862 vs. 0.523,
respectively; p < 0.001). With a cut-off SIS ratio of 1.50, ROC curve analysis showed a sensitivity of 80.0% and specificity
of 84.6% in bone SPECT/CT. The SIS ratio measured in SPECT/CT, but not that measured in bone scintigraphy, was
significantly increased with a higher grade of SI joint changes in plain radiography (p = 0.014).
Conclusion: Bone SPECT/CT is more useful than conventional bone scintigraphy in identifying sacroiliitis in early axial
SpA patients, even with mild SI joint changes in plain radiography. By combining CT, we can accurately delineate the
sacrum and SI joint uptake with our VOI method.
Keywords: SPECT/CT, Bone scintigraphy, Sacroiliitis, SIS ratio, Axial spondyloarthritisBackground
Axial spondyloarthritis (SpA) is one of the important
causes of inflammatory back pain. Axial SpA involves
the axial spine, particularly the sacroiliac (SI) joint and is
known to be associated with HLA-B27 [1]. Ankylosing
spondylitis (AS), the key disease entity of axial SpA, is* Correspondence: debobkr@gmail.com; kideb1@snu.ac.kr
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graphic change. Of note, detection of sacroiliitis by im-
aging studies is important in diagnosing AS [2]. Plain
radiography has been the mainstay imaging modality for
AS and is also essential for evaluating disease progres-
sion [3,4]. The early form of axial SpA (early axial SpA)
is an axial SpA without plain radiographic change and
diagnosed by clinical characteristics or magnetic reson-
ance imaging (MRI). Recently, new treatment option
(TNF-α therapy, etc.) for axial SpA necessitate early de-
tection of early axial SpA [5].
Bone scintigraphy also has been used for assessing
sacroiliitis. The SI joint to sacrum uptake ratio [sacroiliacis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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an increased SIS ratio is found mostly in AS patients com-
pared with healthy controls [6,7]. Prominent SI joint up-
take and the increased SIS ratio in bone scintigraphy
generally portray an advanced stage of sacroiliitis. How-
ever, the SIS ratio measured in bone scintigraphy uses a
rectangular region of interest that does not represent the
accurate uptake of the SI joint and sacrum [8]. Previous
studies have tackled the possible limitation of conventional
bone scintigraphy in detecting the early manifestations of
axial SpA [9-12].
Computed tomography (CT) has been validated for
the diagnosis of axial SpA, especially when there are
structural changes in the SI joint [13,14]. Recently, mag-
netic resonance imaging (MRI) has been incorporated as
an imaging tool for the new assessment of spondyloar-
thritis international society (ASAS) classification criteria
of axial SpA [15-19]. The ASAS/OMERACT MRI group
has recently published definitions of MRI findings in
axial SpA. In general, MRI is a useful imaging tool to
demonstrate bone marrow edema, osteitis, and enthesi-
tis; however, the cost or accessibility of MRI can become
a limiting factor.
In recent years, single positron emission computed
tomography (SPECT)/CT has been used in various fields
in medicine for functional and anatomical imaging [20];
SPECT/CT increased specificity compared with SPECT
in clinical practice by conjoining the anatomical informa-
tion provided by CT [21,22]. Compared with conventional
bone scintigraphy, SPECT/CT can exclude physiological
uptake and better characterize equivocal lesions [23]. In
the musculoskeletal field, SPECT/CT can help delineate
changes of bone adjacent to the synovial surface. Bone
SPECT was shown to be superior to bone scintigraphy in
measuring the SIS ratio [24]; thus, the fusion of SPECT
and CT may further provide useful information in detect-
ing early sacroiliitis [25]. To date, no study exists regarding
bone SPECT/CT findings in early axial SpA.
In this study, we investigated the characteristics of
bone SPECT/CT imaging with volume of interest (VOI)
analysis in early axial SpA patients, comparing the find-




Between March 2011 and December 2012, 20 patients
with inflammatory back pain (IBP) meeting the Amor
criteria for SpA (range: 5–10) yet with minimal or no
change in the SI joint in plain radiography were prospect-
ively enrolled at the Seoul Metropolitan Government-
Seoul National University Hospital Boramae Medical
center (SMG-SNU Boramae Medical center) [26]. Patients
met four or more of the following five criteria of IBP:improvement with exercise, pain at night, insidious onset,
age at onset < 40 years, and no improvement with rest
[27]. Symptom onset had to be less than 5 years. As a con-
trol group, 13 individuals with mechanical hip or back
pain, no history of trauma or injury in the area of interest,
and no abnormal findings in plain radiography were in-
cluded. The patients involved in our study underwent
bone scintigraphy and bone SPECT/CT for purpose of re-
search. Written informed consent for participation in this
study was obtained from participants. This study was ap-
proved by the Institutional Review Board of SMG-SNU
Boramae Medical center.
Bone scintigraphy and bone SPECT/CT acquisition
Bone scintigraphy was performed 3 hours after injection
of 1110 MBq (30 mCi) Tc-99 m-hydroxy-diphosphonate
(HDP). Next, we obtained bone SPECT/CT images using
the Hawkeye 4 system (GE Healthcare, Milwaukee, WI,
USA); low-dose CT and SPECT images were acquired in
turn for 10 and 20 min, respectively. CT images were
obtained using 5.0 mm slices and 512 × 512 matrices
with a standard filter (140 kV, 2.5 mA). SPECT images
were acquired using a 1.5X zoom, 128 × 128 matrices,
and a step–and-shoot scan mode. Fusion of CT and
SPECT images was performed automatically using in-
trinsic software.
Analysis of sacroiliac joint lesions
The SIS ratio was measured by both bone scintigraphy
and bone SPECT/CT. For bone scintigraphy, rectangular
regions of interest (ROIs) were drawn on both SI joints
and the sacrum from the posterior planar image. The
mean uptake was used to estimate the SIS ratio in bone
scintigraphy [7].
In SPECT/CT, the VOI was used to measure the up-
take in both SI joints and the sacrum. VOI was defined
using CT images of SPECT/CT. SI joint was defined by
the space between sacrum and iliac bone from the start
to end of the SI joint. The VOI of the SI joint was de-
fined by the surface of iliac bone and sacrum, the short-
est line between the edge of iliac bone and sacrum on
each transaxial CT image (Figure 1a). VOI of the sacrum
was defined by the bone margin from the start to end of
the sacrum on each transaxial CT images (Figure 1b).
Each VOI was reconstructed three-dimensionally. After
determining the VOI of the SI joint (Figure 1c) and
sacrum (Figure 1d), the mean uptake of each VOI in
SPECT was used to calculate the SIS ratio. Two individ-
uals performed the VOI measurement of SI joints twice
for reproducibility.
In plain radiography, the degree of sacroiliitis was
graded according to a 5-point grading system (0 = nor-
mal, 1 = suspicious, 2 = sclerosis and some erosions, 3 =
severe erosions, widening of the joint space and some
Figure 1 The volume of interest (VOI) of sacroiliac (SI) joint and sacrum for SI joint to sacrum (SIS) uptake ratio. The VOI images of SI
joint (a) and sacrum (b) defined in transxial image of bone single positron emission computed tomography-computed tomography (SPECT/CT).
Three-dimensional (3D) reconstructed VOI images of SI joint (c) and sacrum (d) used to calculate the SIS uptake ratio in bone SPECT/CT.
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was analyzed by two radiologists specialized in musculo-
skeletal radiology, who were blinded to patient’s clinical
findings. The final report with which both radiologists
concurred was used in this study.
Statistical analysis
First, we compared the clinical characteristics and labora-
tory tests between early axial SpA patients and control
subjects. Continuous parameters (age when diagnosis was
made, age of symptom onset, symptom duration, body
mass index [BMI], erythrocyte sedimentation rate [ESR],
C-reactive protein [CRP]) were analyzed by Mann–Whitney
U test, and categorical parameters (gender ratio, HLA-
B27, peripheral arthritis, enthesitis, uveitis, family history
of SpA) were studied by Fisher’s exact test. Reproducibility
test was performed for bone SPECT/CT VOI analysis
using intra-class correlations (ICC) and coefficients of
variation (CV). And the SIS ratio of bone scintigraphy and
bone SPECT/CT between early axial SpA patients and
controls was compared using Mann–Whitney U test. Re-
ceiver operating characteristic (ROC) curve analysis was
performed for bone scintigraphy and bone SPECT/CT,
along with area under the curve (AUC), cut-off value,
sensitivity, and specificity of each modality. Lastly,
Kruskal-Wallis test was used to compare the SIS ratio of
bone SPECT/CT among different grades of sacroiliitis inplain radiography. All statistical analyses were lesion
based and performed using SPSS software (ver. 18.0;
SPSS Inc., Chicago, IL, USA) and MedCalc (MedCalc
Inc., Mariakerke, Belgium). A p-value less than 0.05 was
deemed to indicate statistical significance.Results
Patient characteristics
The mean age of the 20 early axial SpA patients was 35.3 ±
12.5 years (male: female ratio = 12:8, age range = 17–65
years). The mean age of symptom onset was 33.2 ±
13.5 years (age range = 10–65 years), and the mean symp-
tom duration was 24.0 ± 18.4 months (range = 1–60
months). No significant difference was noted in age, age of
symptom onset, symptom duration and BMI between
axial SpA patients and control subjects. Early axial SpA
patients showed significant positive symptoms of HLA-
B27 (p = 0.002), and peripheral arthritis (p = 0.002), and in-
creased ESR (p = 0.032) and CRP (p = 0.004) compared
with control subjects. Other parameters showed no signifi-
cant change (Table 1).Reproducibility of bone SPECT/CT VOI analysis
ICC and %CV of bone SPECT/CT VOI analysis were
0.814 (range = 0.696-0.886, p < 0.001) and 5.6%, respect-
ively, which demonstrates reliable reproducibility.






Age when diagnosis was
made (yr)
35.3 ± 12.5 42.5 ± 13.4 0.128
Age of symptom onset (yr) 33.2 ± 13.5 34.2 ± 13.4 0.945
Body mass index (BMI) 24.2 ± 4.5 23.8 ± 1.4 0.905
Gender ratio (M:F) 12:8 4:9 0.157
HLA-B27 (+) 10/20 0/13 0.002*
Peripheral arthritis (+) 10/20 0/13 0.002*
Enthesitis (+) 3/20 0/13 0.261
Uveitis (+) 1/20 0/13 1.000
Family history of SpA (+) 2/20 0/13 0.507
ESR (mm/h) 27.9 ± 7.0 10.5 ± 3.2 0.032*
CRP (mg/L) 1.7 ± 0.6 0.2 ± 0.1 0.004*
SpA = spondyloarthritis; ESR = erythrocyte sedimentation rate; CRP = C-reactive
protein.
*Statistically significant.
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patients and control subjects
A significant increase in the SIS ratio was observed in
early axial SpA patients compared with control subjects
by bone SPECT/CT (1.68 ± 0.29 vs. 1.43 ± 0.14, respect-
ively; p < 0.001). However, no significant difference in
the SIS ratio was found between early axial SpA patients
and control subjects by bone scintigraphy (1.10 ± 0.21 vs.
1.12 ± 0.17, respectively; p = 0.916) (Figures 2 and 3).
ROC curve analysis of the SIS ratio in bone SPECT/CT and
bone scintigraphy
ROC curve analysis showed an AUC of 0.862 by bone
SPECT/CT [95% confidence interval (CI) = 0.736 – 0.987;Figure 2 Comparison of SIS ratio between early axial SpA and
control subjects. A significant difference of SIS ratio was found in
early axial SpA patients compared with control subjects by bone
SPECT/CT (1.68 ± 0.29 vs. 1.43 ± 0.14, respectively; p < 0.001).
However, no significant difference was detected by bone
scintigraphy (1.10 ± 0.21 vs. 1.12 ±0.17, respectively; p = 0.916).p < 0.001] and 0.523 by bone scintigraphy (95% CI = 0.310 –
0.737; p = 0.832). The ROC curves of the two imaging
modalities were significantly different (p < 0.001). Bone
SPECT/CT revealed a sensitivity of 80.0% and specificity
of 84.6% with an SIS ratio cut-off value of 1.50, whereas
bone scintigraphy showed a sensitivity of 65.0% and speci-
ficity of 53.9% with a cut-off value of 1.08 (Figure 4).
Analysis of the SIS ratio of bone SPECT/CT according to
plain radiography
A total of 40 SI joints of early axial SpA patients were
graded by plain radiography. The number of SI joints
with a grade of 0, 1, or 2 was 15, 18, or 7, respectively.
The SIS ratio of bone SPECT/CT increased in grade 1
or 2 of sacroiliitis than grade 0 of plain radiography
(grade 0 = 1.54 ± 0.18, grade 1 = 1.80 ± 0.31, and grade 2 =
1.81 ± 0.19, p = 0.007). Statistically significant group dif-
ference was found between grade 0 vs. grade 1 and grade
0 vs. grade 2 of plain radiography in post hoc analysis In
bone scintigraphy, no significant difference in the SIS ra-
tio among sacroiliitis grades was identified (p = 0.065)
(Table 2).
Discussion
Plain radiography has been the mainstay of SI joint im-
aging; however, this modality is mainly useful in identify-
ing advanced stages of axial SpA, usually AS. In addition,
CT alone is an imperfect imaging modality for diagnosing
active sacroiliitis [29]. In the present study, we investigated
the usefulness of bone SPECT/CT with VOI analysis for
early axial SpA, the early stage of the axial SpA. We dem-
onstrated that bone SPECT/CT is advantageous over con-
ventional bone scintigraphy in detecting sacroiliitis. With
the findings of CT, bone SPECT/CT not only can better
delineate the anatomy and joint damage but also can iden-
tify the volume of the SI joint and sacrum, leading to a
better estimation of the SIS ratio. As we used same radio-
tracer for bone scintigraphy and bone SPECT/CT image
acquisition (Tc-99 m-HDP) with one injection of radio-
tracer, there is no further radiation due to SPECT image
acquisition. Furthermore, CT of SPECT/CT scanner of
this study is combined low-dose CT which could mini-
mize the radiation exposure by CT to the patient.
Tc-99 m-HDP is specifically absorbed to the bone, and
the radiotracer uptake depends on local blood flow and
rate of extraction of the bone [30]. The bony changes of
early SpA in the axial bone can induce increased Tc-
99 m-HDP uptake and can be identified by SPECT/CT.
To prove this, we introduced a new method of SIS ratio
measurement in SPECT/CT with the mean uptake in a
pre-defined volume of the SI joint and sacrum. Previous
studies in the nuclear medicine field had some draw-
backs in quantifying the SIS ratio due to overlapping of
the adjacent structures without a definite demarcation of
Figure 3 An example of an early axial spondyloarthritis (SpA) patient (a–d). Transaxial images of bone SPECT (a) and SPECT/CT
(b) demonstrated uptake in SI joints with high SIS ratios of 1.86 (right) and 1.62 (left). The posterior image of bone scintigraphy (c) showed normal SIS
ratios of 1.11 (right) and 1.09 (left). The anterior image of plain radiography (d) showed SI joint grades of 1 (right) and 0 (left). An example of a control
subject (e–h). Transaxial images of bone SPECT (e) and SPECT/CT (f) showed comparable SIS ratios of 1.04 (right), and 1.22 (left). The posterior image of
bone scintigraphy (g) showed normal SIS ratios of 1.09 (right) and 0.91 (left). The anterior image of plain radiography (h) showed an SI joint grade of 0
(both sides).
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usefulness of early detection of AS by bone scintigraphy
[31,32] or SPECT alone [33]; however, their conclusions
are not commonly accepted, and shows limited value for
diagnosing probable or suspected AS as well as established
AS [8]. SPECT offers more information than planar im-
aging of the SI joint; however, accurate delineation of the
SI joint or sacrum is nearly impossible. SPECT/CT pro-
vides much more precise information and resolution of
the area of interest than planar imaging obtained by bone
scintigraphy and SPECT. Furthermore, using the CTFigure 4 Receiver operating characteristic (ROC) curve analysis
of bone SPECT/CT and bone scintigraphy. The area under the
curve (AUC) of bone SPECT/CT was 0.862 (p < 0.001) and that of bone
scintigraphy was 0.523 (p = 0.832). Bone SPECT/CT showed a sensitivity
of 80.0% and specificity of 84.6% with a cut-off SIS ratio of 1.50.image for delineating the sacrum and SI joint decreased
the inter-observer variation.
As our aim was to investigate the difference in the SIS
ratio between SPECT/CT and bone scintigraphy in early
axial SpA, ROC curve analysis of both bone SPECT/CT
and bone scintigraphy was performed to predict the best
cut-off value to aid in the diagnosis of early axial SpA. A
SIS ratio greater than 1.50 by SPECT/CT demonstrated
the best sensitivity (80.0%) and specificity (84.6%). In
fact, the optimal cut-off value of the SIS ratio may differ
depending on the radiopharmaceutical and imaging mo-
dality. For instance, a SIS ratio greater than 1.2 has been
commonly observed in patients with sacroiliitis in con-
ventional bone scintigraphy. A recent study showed a
SIS ratio cut-off value of 1.3 for F-18-fluoride PET-CT
in AS [34]. Another study report that F-18-fluoride PET/
CT, the bone turnover radiotracer, was useful to diagnose
ankylosing spondylitis, while F-18-FDG PET/CT was not
[35]. We hypothesized that Tc-99 m-HDP is also the bone
turnover agent like F-18-fluoride, it reflected early SpA
well, and expect it can be used with lower cost and avail-
ability compared with F-18-fluoride PET/CT.Table 2 Analysis of the SIS ratio of bone SPECT/CT








Bone SPECT/CT 1.54 ± 0.18 1.80 ± 0.31 1.81 ± 0.19 0.007*
Bone scintigraphy 1.00 ± 0.20 1.17 ± 0.18 1.17 ± 0.16 0.065
SIS = sacroiliac joint to sacrum, SPECT/CT = single positron emission computed
tomography/computed tomography; SI = sacroiliac.
*Statistically significant group difference exists between grade 0 vs. grade 1
and grade 0 vs. grade 2 of plain radiography in post hoc analysis.
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tle changes of sacroiliitis by plain radiography (grade 0
vs. grade 1 or 2), in contrast to bone scintigraphy. Previ-
ous studies have shown that the SIS ratio in bone scin-
tigraphy is greater in advanced SI joint lesions by plain
radiography [36]. However, this finding was only appre-
ciated in sacroiliitis of grade 3 or higher; in other words,
AS, the late form of axial SpA [3]. All 20 axial SpA pa-
tients in our study met the Amor criteria without evident
plain radiography findings (early axial SpA; less than grade
2). Thus, our data indicate that bone SPECT/CT is more
useful in identifying early changes in the SI joint compared
with conventional bone scintigraphy.
There are several limitations in our study. First, this
study consists of relatively small number of early axial
SpA patients. As the purpose of our study was to specif-
ically demonstrate the bone SPECT/CT SI joint findings
in early SpA patients, we did not obtained clinical data
associated with disease activity, such as Bath ankylosing
spondylitis disease activity index (BASDAI) or patient’s
global assessment. In addition, MRI comparison data for
diagnosis of early axial SpA, and predicting and moni-
toring treatment response using bone SPECT/CT needs
to be evaluated in the future [37]. We are planning a
prospective comparative study using bone SPECT/CT,
F-18-fluoride PET/CT [34] and MRI [38,39] for the diag-
nosis of early axial SpA with long-term follow up. Lastly,
advantages of follow-up imaging with SPECT/CT would
be need to be weighed against repeated radiation expos-
ure and should be considered carefully.
Conclusions
The SIS ratio obtained by bone SPECT/CT, is more use-
ful than conventional bone scintigraphy or plain radiog-
raphy in diagnosing early axial SpA. Low-dose CT adds
structural information and helps detailed VOI informa-
tion of the SI joint and sacrum. We propose 1.50 as the
cut-off SIS ratio to consider for the diagnosis of early
axial SpA by bone SPECT/CT.
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